NEOBIOMICS
Live / Allowed — Published for opposition (as of 21 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79437559
- Mark type
- Stylized text
- Filed
- 19 Sept 2025
- Published for opposition
- 21 Jul 2026
- Attorney of record
- John Alumit
Goods and services
- Class 005 — Pharmaceuticals: Food for babies; infant formula; food supplements; nutritional supplements; food supplements for non-medical purposes; vitamin supplements; dha algae oil dietary supplements; medicinal preparations and substances, namely, dietary supplements; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating sensory organ disorders; probiotic supplements; probiotic bacterial formulations for medical use; prebiotic supplements; dietary and nutritional supplements; protein dietary supplements; probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system; bacterial preparations for medical purposes; pharmaceutical preparations for treating gastrointestinal disorders; medicines for the treatment of gastrointestinal diseases; all the aforementioned products intended for infants
- Class 010 — Medical apparatus: Intravenous feeding tubes; probes for medical purposes; enteral feeding tubes; feeding aids, namely, baby feeding pacifiers, feeding bottles, feeding bottle teats, enteral feeding pumps, and pacifiers for babies; intravenous feeding bottles; feeding bottle teats; breast milk storage bottles; feeding bottles for food supplements and infant formula; apparatus, devices and articles for nursing infants, namely, breast pumps, breast milk storage bags, nursing bottles
- Class 042 — Scientific and technological services: Science and technology services, namely, research and design in the field of food supplements; neonatal medical research services; medical research; biomedical research services; research on the subject of pharmaceuticals; research relating to food supplements; medical research in the neonatal field; all of the foregoing excluding services in the field of oncology
Owner
- Neobiomics AB, Solna, SE
- Neobiomics AB, Solna, SE
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 06 Aug 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2026 — PUBLISHED FOR OPPOSITION
- 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Mar 2026 — REFUSAL PROCESSED BY IB
- 28 Feb 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 28 Feb 2026 — REFUSAL PROCESSED BY MPU
- 31 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 30 Jan 2026 — NON-FINAL ACTION WRITTEN